SG10201911974UA - Apoc-ii mimetic peptides - Google Patents

Apoc-ii mimetic peptides

Info

Publication number
SG10201911974UA
SG10201911974UA SG10201911974UA SG10201911974UA SG10201911974UA SG 10201911974U A SG10201911974U A SG 10201911974UA SG 10201911974U A SG10201911974U A SG 10201911974UA SG 10201911974U A SG10201911974U A SG 10201911974UA SG 10201911974U A SG10201911974U A SG 10201911974UA
Authority
SG
Singapore
Prior art keywords
apoc
mimetic peptides
mimetic
peptides
Prior art date
Application number
SG10201911974UA
Other languages
English (en)
Inventor
Alan Remaley
Soumitra Ghosh
Madhav Devalaraja
Chih-Hung Lo
Denis Sviridov
Anna Wolska
Original Assignee
The United States Of America As Represented By The Secretary Department Of Health & Human Services
Corvidia Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The United States Of America As Represented By The Secretary Department Of Health & Human Services, Corvidia Therapeutics Inc filed Critical The United States Of America As Represented By The Secretary Department Of Health & Human Services
Publication of SG10201911974UA publication Critical patent/SG10201911974UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1722—Plasma globulins, lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG10201911974UA 2017-01-19 2018-01-19 Apoc-ii mimetic peptides SG10201911974UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762448358P 2017-01-19 2017-01-19
US201762476531P 2017-03-24 2017-03-24
US201762476535P 2017-03-24 2017-03-24

Publications (1)

Publication Number Publication Date
SG10201911974UA true SG10201911974UA (en) 2020-02-27

Family

ID=62908746

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201911974UA SG10201911974UA (en) 2017-01-19 2018-01-19 Apoc-ii mimetic peptides
SG11201906422VA SG11201906422VA (en) 2017-01-19 2018-01-19 Apoc-ii mimetic peptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201906422VA SG11201906422VA (en) 2017-01-19 2018-01-19 Apoc-ii mimetic peptides

Country Status (14)

Country Link
US (2) US11136372B2 (fr)
EP (1) EP3571216A4 (fr)
JP (2) JP7353973B2 (fr)
KR (1) KR20190121305A (fr)
CN (1) CN110831957B (fr)
AU (1) AU2018210404B2 (fr)
BR (1) BR112019014707A2 (fr)
CA (1) CA3050106A1 (fr)
IL (2) IL268093B1 (fr)
MX (1) MX2019008529A (fr)
NZ (1) NZ755599A (fr)
SG (2) SG10201911974UA (fr)
TW (2) TW202130652A (fr)
WO (1) WO2018136803A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201911974UA (en) 2017-01-19 2020-02-27 The United States Of America As Represented By The Secretary Department Of Health & Human Services Apoc-ii mimetic peptides
EP4359432A2 (fr) * 2021-06-23 2024-05-01 The United States of America, as represented by The Secretary, Department of Health and Human Services Peptides mimétiques d'apoc-ii courts et méthodes d'utilisation
WO2023215838A1 (fr) * 2022-05-05 2023-11-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptides mimétiques d'apolipoprotéine e courte et procédés d'utilisation
WO2024036145A1 (fr) * 2022-08-07 2024-02-15 Protean Bio, Inc. Peptides pour la survie de cellules bêta et la production d'insuline

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0206448B1 (fr) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hémoglobine liée à un poly(oxyde d'alkylène)
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US6156727A (en) * 1996-09-05 2000-12-05 Uab Research Foundation Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis
PL372925A1 (en) 2001-09-28 2005-08-08 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
US7220576B2 (en) * 2002-01-07 2007-05-22 Lifesensors, Inc. Methods and compositions for protein expression and purification
US7319170B2 (en) * 2003-01-17 2008-01-15 Merck & Co., Inc. N-cyclohexylaminocarbonyl benzensulfonmide derivatives
CA2549529A1 (fr) * 2003-12-15 2005-06-30 The Regents Of The University Of California Peptides synthetiques helicoidaux stimulant la sortie du cholesterol des cellules
CA2555409A1 (fr) * 2004-02-19 2005-09-01 Banyu Pharmaceutical Co., Ltd. Nouveau derive de sulfonamide
CA2574007A1 (fr) 2004-07-16 2006-02-23 Trustees Of Tufts College Substance mimetique d'alipoproteine a1 et ses utilisations
AU2006263332B2 (en) * 2005-06-29 2012-02-23 Hadasit Medical Research Services & Development Ltd. Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
WO2008039843A2 (fr) * 2006-09-26 2008-04-03 Lipid Sciences, Inc. Nouveaux peptides promouvant l'ecoulement lipidique
WO2009097584A1 (fr) * 2008-01-30 2009-08-06 Proteogenix, Inc. Biomarqueurs de sérum maternel pour la détection de pré-éclampsie
WO2009129263A1 (fr) * 2008-04-15 2009-10-22 The Government Of The Usa As Represented By The Secretary Of The Department Of Health & Human Serv. Peptides favorisant l’efflux de lipides via abca1 et activant une lipoprotéine lipase
EP2484692A4 (fr) * 2009-09-30 2013-03-06 Snu R&Db Foundation Peptides mimétiques d'apolipoprotéine a-1, et agent thérapeutique pour traiter l'hyperlipidémie et maladies associées à l'hyperlipidémie comprenant ceux-ci
US10087234B2 (en) 2012-11-06 2018-10-02 Les Hopitaux Universitaires De Geneve Mimetic peptides
SG10201911974UA (en) 2017-01-19 2020-02-27 The United States Of America As Represented By The Secretary Department Of Health & Human Services Apoc-ii mimetic peptides
EA201991491A1 (ru) 2017-03-24 2019-12-30 Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сервисис Миметические пептиды apoc-ii

Also Published As

Publication number Publication date
CN110831957A (zh) 2020-02-21
IL268093A (en) 2019-09-26
WO2018136803A8 (fr) 2019-08-01
TW202130652A (zh) 2021-08-16
US11827690B2 (en) 2023-11-28
EP3571216A1 (fr) 2019-11-27
US20200140522A1 (en) 2020-05-07
TWI788323B (zh) 2023-01-01
JP2023116739A (ja) 2023-08-22
SG11201906422VA (en) 2019-08-27
JP2020511425A (ja) 2020-04-16
BR112019014707A2 (pt) 2020-04-07
US20210324043A1 (en) 2021-10-21
CN110831957B (zh) 2024-02-09
IL279831A (en) 2021-03-01
NZ755599A (en) 2022-12-23
JP7353973B2 (ja) 2023-10-02
MX2019008529A (es) 2020-02-07
AU2018210404B2 (en) 2022-01-27
KR20190121305A (ko) 2019-10-25
AU2018210404A1 (en) 2019-08-08
WO2018136803A1 (fr) 2018-07-26
TW201835097A (zh) 2018-10-01
EP3571216A4 (fr) 2020-11-04
CA3050106A1 (fr) 2018-07-26
US11136372B2 (en) 2021-10-05
IL268093B1 (en) 2024-03-01

Similar Documents

Publication Publication Date Title
HK1251612A1 (zh) 包含2a肽的重組載體
IL248175A0 (en) Psidine-deleting peptides and their uses
IL275298B1 (en) Mitochondria-targeted peptides
IL279831A (en) APOC-II mimic peptides
SG11202005653RA (en) Novel peptide
GB201520536D0 (en) Peptides
GB201719557D0 (en) Polypeptide
GB2540116B (en) Collagen mimetic peptide
GB201520546D0 (en) Peptides
GB201520545D0 (en) Peptides
GB201520550D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520541D0 (en) Peptides
GB201520539D0 (en) Peptides
GB201520544D0 (en) Peptides
GB201700557D0 (en) Novel peptides
GB201520542D0 (en) Peptides
GB201520557D0 (en) Peptides
GB201520548D0 (en) Peptides
GB201715379D0 (en) Peptides
GB201715378D0 (en) Peptides
GB201711620D0 (en) Peptides
GB201719520D0 (en) Neuroprotectvie peptide
GB201707837D0 (en) Peptides
GB201708471D0 (en) Polypeptide